Carfilzomib with daratumumab and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)

  • Technology appraisal
  • TA841
  • Published: 

History

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators